| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
|
21.02.2025 12:24:40
|
Change to the Executive Leadership Team
Jacob Vishof Paulsen will be leaving his position as Executive Vice President of Food & Beverage Biosolutions, as he has accepted a role outside of Novonesis, effective March 31, 2025.
Ester Baiget, President & CEO comments: "I want to thank Jacob for his strong leadership and commitment to Novonesis and our Food & Beverage Biosolutions business. Jacob has played an instrumental role in Novonesis. As a result of his contribution, the Food & Beverage Biosolutions business in Novonesis rests on a solid foundation with an extraordinary team and is uniquely positioned to drive continued growth and deliver innovative solutions to our customers. I wish Jacob all the best on his future journey.”
Jacob joined Chr. Hansen in 2006 and became a member of the Corporate Leadership Team in 2013. During his tenure in Chr. Hansen, Jacob has held multiple global sales and business unit leadership positions and since 2019 been responsible for the Food Cultures & Enzymes business unit, before entering his current role in Novonesis.
Jacob Vishof Paulsen, EVP of Food & Beverage Biosolutions continues: "I am proud of having been part of Novonesis and see amazing potential in this company. I am thankful for my time with the company and the tremendous opportunities it has provided. What I will remember the most is the people that I have worked with across the global organization.”
The search for a replacement has been initiated and an announcement will follow in due time.
Contact information
Investor Relations
Tobias Bjorklund +45 3077 8682 tobb@novonesis.com
Anders Enevoldsen +45 5350 1453 adev@novonesis.com
Katrine Spedtsberg Poulsen kats@novonesis.com
Media Relations
Benjamin Hjorth +45 3077 2731 bht@novonesis.com
Attachment
Nachrichten zu Novozymes A-S (B)
|
25.02.25 |
Ausblick: Novozymes A-S (B) mit Zahlen zum abgelaufenen Quartal (finanzen.net) | |
|
11.02.25 |
Novonesis to acquire dsm-firmenich’s share of the Feed Enzyme Alliance (GlobeNewswire) | |
|
11.02.25 |
Erste Schätzungen: Novozymes A-S (B) öffnet die Bücher zum abgelaufenen Quartal (finanzen.net) |
Im BX Morningcall werden folgende Aktien analysiert und erklärt:
✅ Trane Technologies
✅ Deutsche Boerse
✅ Euronext N.V
Pünktlich zum Börsenstart diskutieren Investment-Stratege François Bloch und Börsen-Experte David Kunz oder Olivia Hähnel über ausgewählte Top-Aktienwerte aus dem BX Musterportfolio.
👉🏽 https://bxplus.ch/bx-musterportfolio/
Inside Trading & Investment
Mini-Futures auf SMI
Inside Fonds
Aktien in diesem Artikel
| Novozymes A-S (B) | 44.68 | -6.35% |
|
Meistgelesene Nachrichten
Top-Rankings
Börse aktuell - Live Ticker
China reagiert mit höheren Zöllen auf US-Waren: SMI und DAX mit deutlichen Verlusten -- Wall Street volatil -- Japanische Börse knickt letztlich einDer heimische und der deutsche Aktienmarkt bewegen sich am Freitag tief in der Verlustzone. Die US-Börsen präsentieren sich zum Wochenschluss schwankungsreich. An den asiatischen Aktienmärkten ging es vor dem Wochenende in unterschiedliche Richtungen.
finanzen.net News
| Datum | Titel |
|---|---|
|
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
|
{{ARTIKEL.NEWS.BODY.TITEL}} |